Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
5.20
+0.06 (1.17%)
Sep 30, 2026, 3:04 PM CST

SHE:002688 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,9152,8602,3662,1682,1172,072
Other Revenue
20.1318.094.996.045.825.8
2,9362,8782,3712,1742,1232,078
Revenue Growth
8.92%21.41%9.04%2.42%2.15%14.51%
Cost of Revenue
1,9431,9441,6411,5721,5451,472
Gross Profit
992.09934.59729.97602.51577.47605.66
Selling, General & Admin
533.12502.09401.98367.95352.78316.37
Research & Development
112.15116.55947482.2872.25
Other Operating Expenses
25.7313.38.145.827.7512.15
Operating Expenses
677.02635.51518.11454.08444.34402.65
Operating Income
315.07299.09211.85148.43133.13203.01
Interest Expense
-86.38-89.94-80.34-60.03-36.41-52.34
Interest & Investment Income
12.998.166.98.371.91.72
Currency Exchange Gain (Loss)
-22.89-8.788.928.8540.34-8.83
Other Non Operating Income (Expenses)
-4.31-3.55-28.48-7.33-15.79-4.87
EBT Excluding Unusual Items
214.48204.97118.8598.29123.18138.68
Impairment of Goodwill
-174.99-174.99-39.77-5.62-7.74-11.04
Gain (Loss) on Sale of Investments
-1.54-2.4-1.22-1.52-3.94-
Gain (Loss) on Sale of Assets
-2.82-2.660.19-0.36-0.254.87
Asset Writedown
-4.39-3.82-1.11-0.93-0.46-1.28
Other Unusual Items
25.2918.0520.8311.658.0511.69
Pretax Income
56.0239.1597.78101.5118.84142.91
Income Tax Expense
69.7850.1313.467.060.7320.82
Earnings From Continuing Operations
-13.76-10.9884.3294.43118.11122.09
Minority Interest in Earnings
34.2938.5415.88-7.98-42.5-28.1
Net Income
20.5327.56100.286.4675.6293.99
Net Income to Common
20.5327.56100.286.4675.6293.99
Net Income Growth
-86.04%-72.50%15.90%14.34%-19.55%-19.89%
Shares Outstanding (Basic)
780781774780780696
Shares Outstanding (Diluted)
780781774780780696
Shares Change
1.24%0.81%-0.76%-0.01%12.16%6.74%
EPS (Basic)
0.030.040.130.110.100.14
EPS (Diluted)
0.030.040.130.110.100.14
EPS Growth
-86.21%-72.72%16.79%14.34%-28.27%-24.94%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
259.13148.64136.18-258.45-277.69-230.74
Free Cash Flow Per Share
0.330.190.18-0.33-0.36-0.33
Dividend Per Share
0.1000.1000.1000.1000.100-
Dividend Growth
0%0%0%0%0%-
Gross Margin
33.80%32.47%30.79%27.71%27.20%29.15%
Operating Margin
10.73%10.39%8.94%6.83%6.27%9.77%
Profit Margin
0.70%0.96%4.23%3.98%3.56%4.52%
Free Cash Flow Margin
8.83%5.17%5.75%-11.89%-13.08%-11.10%
EBITDA
553.72528.74397.33321.3282.31333.98
EBITDA Margin
18.86%18.37%16.76%14.78%13.30%16.07%
D&A For EBITDA
238.65229.66185.47172.86149.18130.97
EBIT
315.07299.09211.85148.43133.13203.01
EBIT Margin
10.73%10.39%8.94%6.83%6.27%9.77%
Effective Tax Rate
124.56%128.06%13.77%6.96%0.61%14.57%
Revenue as Reported
2,9362,8782,3712,1742,1232,078
Advertising Expenses
-34.6427.7420.6412.165.36